Evidence map›Paper›PMID 34112736›Full record

ReviewInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2021

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Dirk Timmerman, François Planchamp, Tom Bourne, Chiara Landolfo, Andreas du Bois, Luis Chiva, David Cibula, Nicole Concin, Daniela Fischerova, Wouter Froyman and 11 more

Abstract readReviewConsensus Statement
In one paragraph

Review in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Guideline
  4. Article
  5. Article
  6. Article
  7. Comparative Diagnostic Performance of IOTA Simple Rules, O-RADS US, and Subjective Assessment in Differentiating Benign from Malignant Adnexal Masses.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Dirk TimmermanGynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium Dirk.timmerman@uzleuven.be.ORCID 0000-0002-3707-6645
François PlanchampClinical Research Unit, Institut Bergonie, Bordeaux, France.
Tom BourneGynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium.ORCID 0000-0003-1421-6059
Chiara LandolfoWoman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.ORCID 0000-0001-9808-7957
Andreas du BoisGynaecology and Gynaecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
Luis ChivaGynaecology and Obstetrics, University Clinic of Navarra, Madrid, Spain.ORCID 0000-0002-1908-3251
David CibulaObstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0001-6387-9356
Nicole ConcinGynaecology and Gynaecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.ORCID 0000-0002-9795-2643
Daniela FischerovaObstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0002-7224-3218
Wouter FroymanGynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium.ORCID 0000-0002-1398-9124
Guillermo Gallardo MadueñoRadiology, University Clinic of Navarra, Madrid, Spain.ORCID 0000-0002-7502-3544
Birthe LemleyEuropean Network of Gynaecological Cancers Advocacy Groups (ENGAGe) Executive Group, Prague, Czech Republic.
Annika LoftClinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Liliana MereuGynecology and Obstetrics, Gynecologic Oncology Unit, Santa Chiara Hospital, Trento, Italy.
Philippe MoriceGynaecological Surgery, Institut Gustave Roussy, Villejuif, France.
Denis QuerleuGynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.ORCID 0000-0002-3984-4812
Antonia Carla TestaWoman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.ORCID 0000-0003-2217-8726
Ignace VergoteObstetrics and Gynaecology and Gynaecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.
Vincent VandecaveyeRadiology, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-0800-3279
Giovanni ScambiaWoman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Christina FotopoulouGynaecologic Oncology, Hammersmith Hospital, Imperial College, London, UK.ORCID 0000-0001-6375-9645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the pre-operative diagnosis of ovarian tumors, including imaging techniques, biomarkers, and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the pre-operative diagnosis of ovarian tumors and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the pre-operative diagnosis of ovarian tumors and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.

Indexed as

ConsensusEuropeFemaleHumansOvarian NeoplasmsPreoperative Periodovarian neoplasmsovary

Identifiers

PMID34112736
PMCPMC8273689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.